Filing Details

Accession Number:
0001209191-13-055662
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-06 14:15:34
Reporting Period:
2013-12-06
Filing Date:
2013-12-06
Accepted Time:
2013-12-06 14:15:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1218981 Iii S John Stafford 350 N. Orleans, 2N
Chicago IL 60654
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-06 7,260,773 $0.00 7,283,631 No 4 C Direct
Common Stock Acquisiton 2013-12-06 282,572 $0.00 7,566,203 No 4 C Indirect By Drogheda, LLC
Common Stock Acquisiton 2013-12-06 275,000 $5.50 7,841,203 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Indirect By Drogheda, LLC
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Preferred Stock Disposition 2013-12-06 22,508,399 $0.00 7,260,773 $0.00
Common Stock Series A-1 Preferred Stock Disposition 2013-12-06 875,974 $0.00 282,572 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. Every 3.1 shares of the Series A-1 Preferred Stock is convertible into 1 share of the Issuer's Common Stock at any time, at the holder's election, and has no expiration date.
  2. The shares were purchased at the Issuer's initial public offering.